Point72 Middle East FZE’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Point72 Middle East FZE’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,103	Closed	-$25.8K	–	2386
2022 Q4	$25.8K	Buy	+2,103	New	+$50.1K	﹤0.01%	1588

Point72 Middle East FZE's CINC Position: Q1 2023 in Review

Point72 Middle East FZE sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 2,103 shares — an estimated $25.8K sold.

Point72 Middle East FZE first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $25.8K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Point72 Middle East FZE reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Point72 Middle East FZE sold 2,103 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $25.8K.
Point72 Middle East FZE first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Point72 Middle East FZE's CinCor Pharma, Inc. Common Stock position peaked at $25.8K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Point72 Middle East FZE's 13F filing for Q1 2023, filed 15 May 2023.